Abstract
We describe a healthy peripheral blood stem cell (PBSC) donor who developed a cutaneous reaction, erythema exsudativum multiforme, during the administration of granulocyte colony-stimulating factor (G-CSF) for mobilization. The cutaneous lesions were located on his hips, apart from the site of G-CSF injection. Treatment with topical corticosteroid was commenced, and the lesions resolved completely within a week. Adverse cutaneous reactions induced by G-CSF have been reported infrequently in healthy donors. Further documentation of cases and their full evaluation will be of great importance for both physicians and PBSC donor. Bone Marrow Transplantation (2000) 26, 239–240.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Murata M, Harada M, Kato S et al. Peripheral blood stem cell mobilization and apheresis: analysis of adverse events in 94 normal donors Bone Marrow Transplant 1999 24: 1065–1071
Anderlini P, Donato M, Chan K-W et al. Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the MD Anderson Cancer Center experience Transfusion 1999 39: 555–560
Anderlini P, Przepiorka D, Champlin R, Korbling M . Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals Blood 1996 88: 2819–2825
Paul C, Giachetti S, Pinquier L et al. Cutaneous effects of granulocyte colony-stimulating factor in healthy volunteers Arch Dermatol 1998 134: 111–112
Sato N, Sawada K, Takahashi T et al. A time course study for optimal harvest of peripheral blood progenitor cells by granulocyte colony-stimulating factor in healthy volunteers Exp Hematol 1994 22: 973–978
Samlaska CP, Noyes DK . Localized cutaneous reactions to granulocyte colony-stimulating factor Arch Dermatol 1993 129: 645–646
Asnis LA, Gaspari AA . Cutaneous reactions to recombinant cytokine therapy J Am Acad Dermatol 1995 33: 393–410
Takagi S, Ohsaka A, Taguchi H et al. Pyoderma gangrenosum following cytosine arabinoside, aclarubicin and granulocyte colony-stimulating factor combination therapy in myelodysplastic syndrome Int Med 1998 37: 316–319
Sasaki O, Yokoyama A, Uemura S et al. Drug eruption caused by recombinant human G-CSF Int Med 1994 33: 641–643
Glass LF, Fotopoulos T, Messina JL . A generalized cutaneous reaction induced by granulocyte colony-stimulating factor J Am Acad Dermatol 1996 34: 455–459
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mori, T., Sato, N., Watanabe, R. et al. Erythema exsudativum multiforme induced by granulocyte colony-stimulating factor in an allogeneic peripheral blood stem cell donor. Bone Marrow Transplant 26, 239–240 (2000). https://doi.org/10.1038/sj.bmt.1702501
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702501
Keywords
This article is cited by
-
Side Effects of Cytokines Approved for Therapy
Drug Safety (2014)